JPY 787.0
(0.64%)
Breakdown | 2022 | 2021 | 2020 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.47 Billion | 1.71 Billion | 589.33 Million | 2.3 Billion | 1.84 Billion | 2.32 Billion |
Net Income | 2.78 Billion | 2.59 Billion | 1.28 Billion | 2.13 Billion | 3.03 Billion | 3.59 Billion |
Depreciation & Amortization | 970 Million | 973 Million | 910.66 Million | 629 Million | 544 Million | 596 Million |
Deferred income taxes | - | -220 Million | - | -992 Million | -1.1 Billion | -993 Million |
Stock-based compensation | 87 Million | 94 Million | - | 66 Million | 51 Million | 51 Million |
Change in working capital | 159 Million | -685 Million | 86.66 Million | 1.13 Billion | 278 Million | -177 Million |
Other non-cash items | -1.53 Billion | -1.04 Billion | -1.69 Billion | -665 Million | -951 Million | -746 Million |
Investing Cash Flow | -577 Million | -544 Million | -195.99 Million | -343 Million | -894 Million | 316 Million |
Investments in PPE | -457 Million | -595 Million | -497.33 Million | -1.11 Billion | -1.22 Billion | -315 Million |
Acquisitions | -460 Million | 229 Million | - | 3 Million | -67 Million | - |
Investment purchases | -322 Million | -670 Million | - | -10 Million | - | -198 Million |
Sales/Maturities of investments | - | 2 Million | - | -63 Million | - | - |
Other Investing Activities | 662 Million | 490 Million | 301.33 Million | 843 Million | 397 Million | 829 Million |
Financing Cash Flow | -1.31 Billion | -693 Million | -1.44 Billion | -668 Million | -1.98 Billion | -2.03 Billion |
Debt repayment | - | - | - | -117 Million | -517 Million | -1.12 Billion |
Dividends payments | -781 Million | -714 Million | -942.66 Million | -668 Million | -708 Million | -636 Million |
Common Stock Repurchased | -499 Million | - | -665.33 Million | -96 Million | -903 Million | - |
Common Stock Issuance | - | - | - | 249 Million | 196 Million | 100 Million |
Other Financing Activities | -39 Million | 21 Million | 158.66 Million | -36 Million | -50 Million | -371 Million |
Accounts receivables | - | - | 153.33 Million | - | -248 Million | - |
Accounts payables | - | - | - | - | - | - |
Inventory | -396 Million | -439 Million | -66.66 Million | -16 Million | -33 Million | 29 Million |
Other working capital | 555 Million | -246 Million | - | 1.14 Billion | 559 Million | -206 Million |
Cash at beginning of period | 8.28 Billion | 7.98 Billion | - | 7.48 Billion | 8.52 Billion | 7.9 Billion |
Cash at end of period | 8.88 Billion | 8.28 Billion | -1.05 Billion | 8.77 Billion | 7.48 Billion | 8.52 Billion |
Capital Expenditure | -457 Million | -595 Million | -497.33 Million | -1.11 Billion | -1.22 Billion | -315 Million |
Effect of forex changes on cash | 15 Million | 35 Million | 5.33 Million | -4 Million | -13 Million | 5 Million |
Net cash flow / Change in cash | 592 Million | 307 Million | -1.05 Billion | 1.28 Billion | -1.04 Billion | 627 Million |
Free Cash Flow | 2.01 Billion | 1.11 Billion | 91.99 Million | 1.18 Billion | 622 Million | 2 Billion |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 278 Million | 511 Million | 249 Million | 2.78 Billion | 555 Million | 526 Million |
Depreciation & Amortization | - | - | - | 970 Million | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | 87 Million | - | - |
Change in working capital | - | - | - | 159 Million | - | - |
Other non-cash items | -278 Million | -511 Million | -249 Million | -1.53 Billion | -555 Million | -526 Million |
Investing Cash Flow | - | - | - | -577 Million | - | - |
Investments in PPE | - | - | - | -457 Million | - | - |
Acquisitions | - | - | - | -460 Million | - | - |
Investment purchases | - | - | - | -322 Million | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | 662 Million | - | - |
Financing Cash Flow | - | - | - | -1.31 Billion | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | -781 Million | - | - |
Common Stock Repurchased | - | - | - | -499 Million | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | -39 Million | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | -396 Million | - | - |
Other working capital | - | - | - | 555 Million | - | - |
Cash at beginning of period | - | - | - | 8.28 Billion | - | - |
Cash at end of period | - | - | - | 8.88 Billion | - | - |
Capital Expenditure | - | - | - | -457 Million | - | - |
Effect of forex changes on cash | - | - | - | 15 Million | - | - |
Net cash flow / Change in cash | - | - | - | 592 Million | - | - |
Free Cash Flow | - | - | - | 2.01 Billion | - | - |
300919
DGICA
HOV
4074
RMT
002160